# Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

> **NCT03633552** · PHASE3 · UNKNOWN · sponsor: **Mashhad University of Medical Sciences** · enrollment: 62 (estimated)

## Conditions studied

- Glioblastoma Multiforme of Brain
- Anaplastic Astrocytoma of Brain

## Interventions

- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT03633552
- **Lead sponsor:** Mashhad University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-03
- **Primary completion:** 2021-03-03
- **Final completion:** 2021-04-03
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03633552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03633552, "Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03633552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*